Profile data is unavailable for this security.
About the company
Hikal Limited is an India-based company, which is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. The Pharmaceuticals segment produces active pharmaceutical ingredients. Its facilities are in Jigani, Bangalore and Panoli, Gujrat. The Crop protection segment produces pesticides and herbicides. Its facilities are in Taloja, Mahad, Maharashtra and Panoli, Gujarat. Its human health product categories include anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-viral, anti-inflammatory, analgesic and anti-parasitic. Its animal health product categories include anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone and NSAID. Its crop protection product categories include algaecide, biocide, fungicide, herbicide, insecticide and intermediate.
- Revenue in INR (TTM)17.85bn
- Net income in INR696.00m
- Incorporated1988
- Employees2.14k
- LocationHikal LtdGreat Eastern ChambersSector 11, CBD-BelapurNAVI MUMBAI 400614IndiaIND
- Phone+91 2 230973100
- Fax+91 2 227574277
- Websitehttps://www.hikal.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morepen Laboratories Ltd | 16.31bn | 761.19m | 23.95bn | 1.65k | 31.04 | -- | 22.39 | 1.47 | 1.51 | 1.51 | 32.53 | -- | -- | -- | -- | 9,891,111.00 | -- | 7.39 | -- | 13.78 | 35.85 | 32.82 | 4.67 | 5.19 | -- | 27.34 | -- | 0.00 | -8.36 | 18.51 | -61.96 | 5.50 | 11.33 | -- |
| RPG Life Sciences Limited | 5.82bn | 876.60m | 25.05bn | 1.17k | 28.57 | 6.68 | 23.92 | 4.30 | 53.01 | 53.01 | 351.99 | 226.65 | 1.25 | 1.88 | 13.45 | -- | 18.81 | 16.07 | 25.10 | 21.77 | 68.30 | 64.04 | 15.06 | 11.99 | 1.50 | 246.84 | 0.00 | 29.27 | 13.50 | 12.01 | 29.60 | 51.98 | 28.60 | 46.14 |
| Innova Captab Ltd | -100.00bn | -100.00bn | 28.76bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 15.72 | -- | 6.26 | -- | -- | -- |
| SeQuent Scientific Ltd | 13.70bn | -358.69m | 28.94bn | 478.00 | -- | 4.42 | 90.65 | 2.11 | -1.45 | -1.45 | 56.27 | 26.32 | 0.8925 | 2.19 | 4.05 | -- | -1.93 | 1.09 | -3.27 | 1.76 | 44.53 | 42.74 | -2.16 | 1.18 | 0.7602 | 0.1376 | 0.4062 | -- | -3.60 | 5.68 | 70.40 | -- | 6.96 | -- |
| Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 29.46bn | 1.23k | -- | 93.17 | -- | -- | -- | -- | -- | 12.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8228 | -- | 0.2681 | -- | 43.84 | -- | 77.37 | -- | -- | -- |
| Indoco Remedies Ltd | 18.17bn | 984.70m | 29.53bn | 6.10k | 30.45 | 2.66 | 15.63 | 1.62 | 10.52 | 10.52 | 193.15 | 120.38 | 0.9557 | 1.65 | 4.80 | -- | 5.10 | 6.88 | 7.02 | 9.85 | 69.23 | 66.66 | 5.34 | 6.93 | 0.9825 | 4.01 | 0.377 | 12.67 | 8.91 | 13.41 | -30.78 | -- | 34.54 | 37.97 |
| Supriya Lifescience Ltd | 5.54bn | 1.20bn | 30.31bn | 392.00 | 25.16 | -- | 22.40 | 5.47 | 14.97 | 14.97 | 68.93 | -- | -- | -- | -- | 14,144,410.00 | -- | 20.77 | -- | 29.06 | 61.94 | 55.83 | 21.72 | 24.33 | -- | 63.63 | -- | 2.02 | -13.04 | 16.70 | -40.81 | 59.41 | 85.55 | -- |
| Dishman Carbogen Amcis Ltd | 25.80bn | -1.54bn | 30.33bn | 1.30k | -- | -- | 20.58 | 1.18 | -9.84 | -9.84 | 164.35 | -- | -- | -- | -- | 19,919,850.00 | -- | 0.4699 | -- | 0.5665 | 76.93 | 74.36 | -5.98 | 1.82 | -- | -0.1245 | -- | 202.76 | 12.72 | 7.32 | -265.46 | -- | 21.54 | -- |
| Gufic BioSciences Ltd | 7.85bn | 841.95m | 34.57bn | 1.63k | 39.99 | -- | 32.77 | 4.41 | 8.62 | 8.62 | 80.38 | -- | -- | -- | -- | 4,820,074.00 | -- | 12.30 | -- | 23.08 | 51.08 | 44.91 | 10.73 | 9.84 | -- | 8.22 | -- | 1.39 | -11.36 | 17.47 | -16.84 | 37.06 | 86.82 | 14.87 |
| Hikal Ltd | 17.85bn | 696.00m | 36.74bn | 2.14k | 52.73 | 3.09 | 19.62 | 2.06 | 5.65 | 5.65 | 144.77 | 96.32 | 0.7325 | 2.66 | 3.60 | -- | 2.86 | 5.07 | 4.03 | 7.51 | 53.79 | 47.22 | 3.90 | 5.86 | 0.8761 | 2.65 | 0.4077 | 16.88 | -11.79 | 2.34 | -11.20 | -7.55 | 9.72 | 0.00 |
| Unichem Laboratories Ltd | 16.75bn | 145.69m | 39.06bn | 3.12k | 268.51 | -- | 29.97 | 2.33 | 2.07 | 2.07 | 234.69 | -- | -- | -- | -- | 5,364,373.00 | -- | -1.38 | -- | -1.66 | 59.94 | 56.15 | 0.8696 | -3.60 | -- | -0.9613 | -- | -- | 5.76 | 10.51 | -711.67 | -- | -22.60 | -- |
| Advanced Enzyme Technologies Ltd | 6.24bn | 1.33bn | 41.79bn | 338.00 | 31.33 | 3.16 | 24.27 | 6.70 | 11.93 | 11.93 | 55.83 | 118.41 | 0.4219 | 1.06 | 6.27 | -- | 9.26 | 10.82 | 10.23 | 11.93 | 76.83 | 72.81 | 21.95 | 24.59 | 6.22 | 57.81 | 0.0334 | 15.17 | 15.39 | 8.26 | 26.19 | 3.72 | 27.85 | 53.42 |
| Aarti Drugs Ltd | 25.29bn | 1.71bn | 45.10bn | 1.50k | 26.36 | 3.52 | 20.22 | 1.78 | 18.61 | 18.61 | 274.44 | 139.40 | 1.04 | 3.35 | 3.22 | -- | 7.07 | 9.73 | 10.98 | 15.74 | 33.65 | 24.96 | 6.79 | 8.25 | 1.05 | 7.91 | 0.3056 | -- | -6.90 | 10.13 | 3.07 | 13.82 | 24.96 | -- |
| Shilpa Medicare Ltd | 11.23bn | -6.71m | 48.82bn | 1.03k | -- | -- | 45.91 | 4.35 | -0.0714 | -0.0714 | 131.44 | -- | -- | -- | -- | 10,873,050.00 | -- | 3.89 | -- | 4.92 | 64.42 | 60.22 | -0.0538 | 9.29 | -- | 1.16 | -- | 10.65 | -8.33 | 5.82 | -153.54 | -- | 14.58 | -- |
Data as of May 18 2024. Currency figures normalised to Hikal Ltd's reporting currency: Indian Rupee INR
7.02%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Tata Asset Management Ltd.as of 30 Apr 2024 | 3.30m | 2.68% |
| Norges Bank Investment Managementas of 30 Sep 2023 | 2.54m | 2.06% |
| Th�l�me Partners LLPas of 30 Sep 2023 | 1.29m | 1.05% |
| Dimensional Fund Advisors LPas of 09 May 2024 | 847.85k | 0.69% |
| Fiduciary Management, Inc.as of 29 Feb 2024 | 216.19k | 0.18% |
| BlackRock Advisors (UK) Ltd.as of 09 May 2024 | 139.77k | 0.11% |
| BlackRock Fund Advisorsas of 09 May 2024 | 100.88k | 0.08% |
| American Century Investment Management, Inc.as of 09 May 2024 | 86.88k | 0.07% |
| Mellon Investments Corp.as of 09 May 2024 | 74.38k | 0.06% |
| Motilal Oswal Asset Management Co. Ltd.as of 30 Apr 2024 | 61.89k | 0.05% |
More ▼
Data from 31 Dec 2023 - 30 Apr 2024Source: FactSet Research Systems Inc.
